Sergey Nikolaev

14PUBLICATIONS
201CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 15, 2026
TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cells.

|Apr 29, 2026
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.

|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Jan 08, 2026
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.

Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev

|Aug 11, 2023
Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series.

Andrey A Yurchenko, Brice Fresneau, Bruno Borghese

Pageof 3

Frequent Collaborators

6 joint publications

Andrey Yurchenko

4 joint publications

Ismael Padioleau

3 joint publications

Benjamin Besse

3 joint publications

Luc Friboulet